A neuroscientist and biochemist's antiviral lightbulb moment
30 July, 2026While studying how certain processes work inside the human brain, an Australian scientist observed a disruption in a pathway viruses rely on to spread cell to cell.
Antimicrobial resistance in children rises globally — 100K+ samples reveal
23 July, 2026Spanning 82 countries, there was an increase in every region between 2004 and 2022, with the researchers also offering region- and pathogen-specific forecasts to 2035.
Robotic laboratory to fast-track drug invention, trials and commercialisation
22 July, 2026The lab will house an automated system for high-throughput X-ray crystallography, often referred to as HTX, at the Australian Synchrotron in Clayton.
TGA acts on melatonin imports with infringement notices totalling $99K
17 July, 2026Laboratory testing of several imported unregistered melatonin products has confirmed them to be counterfeit. Now, the TGA has issued a company with five infringement notices totalling $99,000.
Protecting particles that carry mRNA in dry vaccine patches
09 July, 2026Combining expertise from RMIT University, MIT and Harvard Medical School, scientists set out to provide practical guidance for future mRNA dry vaccine patch design.
Copper drug clears Alzheimer's proteins — lab experiments reveal
03 July, 2026A drug that delivers copper to the brain has been found to significantly reduce Alzheimer's proteins and improve long-term spatial memory.
Scientists search for cystitis pain 'off switch'
02 July, 2026By targeting certain pain receptors in the bladder, Australian scientists believe that the effects of cystitis — an inflammation of the bladder — could be reduced.
Could this psychedelic compound reduce post-concussion symptoms?
25 June, 2026Few effective therapies exist for concussion. Now, an Australian clinical trial is exploring whether a psychedelic compound found in some mushrooms could help.
Turning point — optimal antibiotics for golden staph bloodstream infections
18 June, 2026Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports a rethink of the default treatment for MSSA and PSSA infections.
Alloy implants that naturally dissolve after healing
04 June, 2026Australian researchers have been developing biodegradable magnesium-based alloys that more closely match the mechanical properties of human bone.
Partnership eyes up gene-editing approaches to vision loss
03 June, 2026A partnership will build on Australian ophthalmic research into mechanisms that damage nerve cells connecting the retina to the brain, leading to irreversible blindness.
Irregular blood pressure patterns and dementia-associated brain changes
29 May, 2026Hypertension has long been recognised as a risk factor for cognitive decline, yet the impact of blood pressure changes throughout the day has been less understood.
AusBiotech partners with Tenmile
28 May, 2026Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced a strategic partnership with a specialist health technology investor.
Australia announces $7.2m diphtheria outbreak response package
21 May, 2026To respond to the biggest diphtheria outbreak on record, support has been announced for the NT Government and the Aboriginal Community Controlled Health Sector.
Multiple myeloma treatment reprograms patients' own immune cells
21 May, 2026An Australian and Victorian Government funding agreement has allowed eligible Australians with multiple myeloma access to a tailor-made blood cancer treatment.
